← Eichor
Study identifier: NCT04927338 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study of Bacopa in Gulf War Illness Patients

Condition: Gulf War Illness  ·  Sponsor: Nova Southeastern University

PhasePhase 2
Planned participants170
Who can joinAll sexes, 46 Years to 78 Years
Healthy volunteersNo

About this study

Gulf War Illness is a condition that affects multiple major organ systems, resulting in a diverse array of symptoms that include debilitating fatigue, memory and cognition difficulties, headaches, sleep disturbances, gastrointestinal problems, skin rashes, and musculoskeletal/joint pain. This phase II, double masked, randomized, placebo-controlled, two-arm study will evaluate cognitive function as evidence of efficacy of the nutraceutical intervention, Bacopa, on central nervous system symptom management of Gulf War Illness, along with assessments of safety of the intervention.

This description comes directly from the study's public registry record.

Talk to the study team

Mayra Vidro, MPH  ·  954-262-2841  ·  mvidro@nova.edu

Karen Kesler, PhD  ·  919-485-1429  ·  kkesler@rti.org

Always discuss trial participation with your own doctor first.

Locations (1)

Nova Southeastern UniversityDavie, Florida, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04927338